Literature DB >> 19252206

Elevated serum advanced glycation end products and their circulating receptors are associated with anaemia in older community-dwelling women.

Richard D Semba1, Luigi Ferrucci, Kai Sun, Kushang V Patel, Jack M Guralnik, Linda P Fried.   

Abstract

OBJECTIVE: to determine whether serum carboxymethyl-lysine, a dominant advanced glycation end product (AGE), and circulating total receptor for AGEs (sRAGE) and endogenous secretory receptor for AGEs (esRAGE) are associated with anaemia.
DESIGN: cross-sectional analysis.
SETTING: moderately severely disabled women, > or =65 years, living in the community in Baltimore, MD (the Women's Health and Aging Study I). PARTICIPANTS: 519 women with and without anaemia. MAIN OUTCOME MEASURE: haemoglobin and anaemia (haemoglobin <12 g/dL).
RESULTS: of 519 women, 128 (24.7%) had anaemia. All odds ratios (OR) were expressed per one standard deviation. Serum CML was associated with anaemia [OR 1.47, 95% confidence interval (CI) 1.11-1.95, P = 0.008] in a multivariate logistic regression model adjusting for age, race, smoking, education and chronic diseases. Serum sRAGE (ng/mL) and esRAGE (ng/mL) were associated with anaemia (OR 1.52, 95% CI 1.21-1.92, P = 0.0004; OR 1.49, 95% CI 1.18-1.87, P = 0.0006, respectively) in separate multivariate logistic regression models, adjusting for the same covariates mentioned above. Serum CML (P = 0.004), sRAGE (P < 0.0001) and esRAGE (P < 0.0001) were inversely and independently associated with haemoglobin concentrations.
CONCLUSION: AGEs and circulating RAGE are independently associated with haemoglobin and anaemia in older women. AGEs are amenable to interventions, as serum AGEs can be lowered by a change in dietary pattern and pharmacological treatment.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19252206      PMCID: PMC2724885          DOI: 10.1093/ageing/afp011

Source DB:  PubMed          Journal:  Age Ageing        ISSN: 0002-0729            Impact factor:   10.668


  29 in total

1.  Improved arterial compliance by a novel advanced glycation end-product crosslink breaker.

Authors:  D A Kass; E P Shapiro; M Kawaguchi; A R Capriotti; A Scuteri; R C deGroof; E G Lakatta
Journal:  Circulation       Date:  2001-09-25       Impact factor: 29.690

2.  Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury.

Authors:  Hideto Yonekura; Yasuhiko Yamamoto; Shigeru Sakurai; Ralica G Petrova; Md Joynal Abedin; Hui Li; Kiyoshi Yasui; Masayoshi Takeuchi; Zenji Makita; Shin Takasawa; Hiroshi Okamoto; Takuo Watanabe; Hiroshi Yamamoto
Journal:  Biochem J       Date:  2003-03-15       Impact factor: 3.857

3.  Randomized trial of an inhibitor of formation of advanced glycation end products in diabetic nephropathy.

Authors:  W Kline Bolton; Daniel C Cattran; Mark E Williams; Sharon G Adler; Gerald B Appel; Kenneth Cartwright; Peter G Foiles; Barry I Freedman; Philip Raskin; Robert E Ratner; Bruce S Spinowitz; Frederick C Whittier; Jean-Paul Wuerth
Journal:  Am J Nephrol       Date:  2003-12-17       Impact factor: 3.754

4.  Elevated serum levels of N(epsilon)-carboxymethyl-lysine, an advanced glycation end product, are associated with proliferative diabetic retinopathy and macular oedema.

Authors:  B O Boehm; S Schilling; S Rosinger; G E Lang; G K Lang; R Kientsch-Engel; P Stahl
Journal:  Diabetologia       Date:  2004-07-17       Impact factor: 10.122

Review 5.  Receptor for advanced glycation endproducts and atherosclerosis: From basic mechanisms to clinical implications.

Authors:  Giuseppina Basta
Journal:  Atherosclerosis       Date:  2007-09-10       Impact factor: 5.162

6.  Low-molecular-weight AGEs are associated with GFR and anemia in patients with type 2 diabetes.

Authors:  Merlin C Thomas; Con Tsalamandris; Richard MacIsaac; Tanya Medley; Bronwyn Kingwell; Mark E Cooper; George Jerums
Journal:  Kidney Int       Date:  2004-09       Impact factor: 10.612

7.  Types of anemia and mortality among older disabled women living in the community: the Women's Health and Aging Study I.

Authors:  Richard D Semba; Michelle O Ricks; Luigi Ferrucci; Qian-Li Xue; Paulo Chaves; Linda P Fried; Jack M Guralnik
Journal:  Aging Clin Exp Res       Date:  2007-08       Impact factor: 3.636

8.  Plasma pentosidine is associated with inflammation and malnutrition in end-stage renal disease patients starting on dialysis therapy.

Authors:  Mohammed E Suliman; Olof Heimbürger; Peter Bárány; Björn Anderstam; Roberto Pecoits-Filho; Ernesto Rodríguez Ayala; A Rashid Qureshi; Ingela Fehrman-Ekholm; Bengt Lindholm; Peter Stenvinkel
Journal:  J Am Soc Nephrol       Date:  2003-06       Impact factor: 10.121

Review 9.  Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes.

Authors:  Giuseppina Basta; Ann Marie Schmidt; Raffaele De Caterina
Journal:  Cardiovasc Res       Date:  2004-09-01       Impact factor: 10.787

10.  Dietary glycotoxins correlate with circulating advanced glycation end product levels in renal failure patients.

Authors:  Jaime Uribarri; Melpomeni Peppa; Wejing Cai; Teresia Goldberg; Min Lu; Suresh Baliga; Joseph A Vassalotti; Helen Vlassara
Journal:  Am J Kidney Dis       Date:  2003-09       Impact factor: 8.860

View more
  3 in total

Review 1.  Does accumulation of advanced glycation end products contribute to the aging phenotype?

Authors:  Richard D Semba; Emily J Nicklett; Luigi Ferrucci
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2010-05-17       Impact factor: 6.053

2.  Endogenous secretory receptor for advanced glycation end products is associated with low serum interleukin-1 receptor antagonist and elevated IL-6 in older community-dwelling adults.

Authors:  Candace L Crasto; Richard D Semba; Kai Sun; Mansi Dalal; Anna Maria Corsi; Stefania Bandinelli; Jack M Guralnik; Luigi Ferrucci
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-02-28       Impact factor: 6.053

3.  Circulating selenium and carboxymethyl-lysine, an advanced glycation endproduct, are independent predictors of anemia in older community-dwelling adults.

Authors:  Cindy N Roy; Richard D Semba; Kai Sun; Stefania Bandinelli; Ravi Varadhan; Kushang V Patel; Jack M Guralnik; Luigi Ferrucci
Journal:  Nutrition       Date:  2012-02-09       Impact factor: 4.008

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.